Pain. Pain, unspecified
Conditions
Interventions
Intervention 1: In Group A(Intervention), immediately before induction of anesthesia a ketorolac 30 mg ampule will be injected intravenously. Intervention 2: In Group B(Intervention), immediately befo
Treatment - Drugs
In Group A(Intervention), immediately before induction of anesthesia a ketorolac 30 mg ampule will be injected intravenously
In Group B(Intervention), immediately before induction of anesthesia a ketorolac 60 mg ampule will be injected intravenously
In Group C(Intervention), immediately before the completion of surgery a ketorolac 30 mg ampule will be injected intravenously
In Group D(Intervention), immediately after the completion of surgery a ketorolac 60 mg ampule will be injected intravenously
In Group E(Control), Ketorolac ampule will not be injected
Sponsors
Research deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with unilateral mandibular fracture Exclusion criteria: Duration of surgery more than 2 hours; Drug abuse by patients; History of systemic disease, History of drug allergy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity. Timepoint: 0, 2, 4, 6, 12,24 hours After surgery. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Sina Mirinejad
Tabriz University of Medical Sciences
Outcome results
None listed